IndexIQ Advisors’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$364K Buy
2,620
+96
+4% +$14.7K 0.01% 934
2021
Q4
$440K Buy
2,524
+370
+17% +$61.7K 0.01% 692
2021
Q3
$357K Buy
2,154
+82
+4% +$14.1K 0.01% 906
2021
Q2
$373K Buy
2,072
+57
+3% +$10.4K 0.01% 835
2021
Q1
$389K Buy
2,015
+253
+14% +$48.7K 0.01% 901
2020
Q4
$356K Buy
1,762
+825
+88% +$171K 0.01% 554
2020
Q3
$197K Buy
937
+567
+153% +$126K 0.01% 656
2020
Q2
$81K Buy
370
+327
+760% +$65.3K ﹤0.01% 859
2020
Q1
$7K Sell
43
-2
-4% -$330 ﹤0.01% 853
2019
Q4
$7K Buy
+45
New +$6.72K ﹤0.01% 687

Other funds holding CLX

IndexIQ Advisors's CLX Position: Q1 2022 in Review

IndexIQ Advisors increased its Clorox (CLX) stake by 3.8% in Q1 2022, buying an estimated $14.7K and bringing the position to 2,620 shares worth $364K. The position accounts for 0.01% of the portfolio, ranked #934.

IndexIQ Advisors first reported a position in CLX in Q4 2019 and has held it in 10 quarters since. The position peaked at $440K in Q4 2021. 1,093 funds tracked by Wall St. Rank hold CLX as of Q1 2022.

  • IndexIQ Advisors held 2,620 shares of Clorox worth $364K as of Q1 2022.
  • IndexIQ Advisors bought 96 Clorox shares in Q1 2022, an estimated $14.7K.
  • Clorox made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #934 holding.
  • IndexIQ Advisors first reported a position in Clorox in Q4 2019 and has held it in 10 quarters since.
  • IndexIQ Advisors's Clorox position peaked at $440K in Q4 2021.
  • 1,093 funds tracked by Wall St. Rank held Clorox as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.